The antiretroviral efficacy of highly active antiretroviral therapy and plasma nevirapine concentrations in HIV-TB co-infected Indian patients receiving rifampicin based antituberculosis treatment

BACKGROUND: Rifampicin reduces the plasma concentrations of nevirapine in human immunodeficiency virus (HIV) and tuberculosis (TB) co-infected patients, who are administered these drugs concomitantly. We conducted a prospective interventional study to assess the efficacy of nevirapine-containing hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Sanjeev, Dhooria, Sahajal, Kumar, Sanjiv, Shah, Nipam, Velpandian, T, Ravi, AK, Kumar, Narendra, Ahmad, Hafeez, Bhargwa, Akshat, Chug, Karan, Bumma, Naresh, Chandrashekhar, Rahul, Ekka, Meera, Sreenivas, Vishnu, Sharma, Surendra K, Samantaray, JC, Mitsuyasu, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223494/
https://www.ncbi.nlm.nih.gov/pubmed/22047185
http://dx.doi.org/10.1186/1742-6405-8-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223494/
https://www.ncbi.nlm.nih.gov/pubmed/22047185
http://dx.doi.org/10.1186/1742-6405-8-41

Ejemplares similares